Sentinel lymphadenectomy in breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2345-2350

  Giuliano, Armando E ^a   Jones, Ralph C ^a   Brennan, Meghan ^a   Statman, Richard ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0030994532     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2345     Document Type: Article

References (39)

1. Kissin MW, Querci della Rovere G, Easton D, et al: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580-584, 1986
2. Larson D, Weinstein M, Goldberg I, et al: Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12:1575-1582, 1986
3. Cabanes P, Salmon R, Vilcoq J, et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 74:126-129, 1992
4. Ivens D, Hoe AL, Podd TJ, et al: Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136-138, 1992
5. Keramopoulos A, Tsionou C, Minaretzis D, et al: Arm morbidity following treatment of breast cancer with total axillary dissection: A multivariate approach. Oncology 50:445-449, 1993
6. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994
7. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995
8. American Joint Committee on Cancer: Breast, in Beahrs OH, Henson DE, Hutter RVP, et al (eds): Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992, pp 149-154
9. Silverstein MJ, Rosser RJ, Gierson ED, et al: Axillary lymph node dissection for intraductal carcinoma: Is it indicated? Cancer 59:1819-1824, 1987
10. Wong JH, Kopald KH, Morton DL: The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125:1298-1302, 1990
11. Silverstein MJ, Gierson ED, Waisman JR, et al: Axillary lymph node dissection for T1a breast carcinoma: Is it indicated? Cancer 73:664-667, 1994
12. Haffty BG, McHann C, Beinfeld M, et al: Breast conservation therapy without axillary dissection. Arch Surg 128:1315-1319, 1993
13. Osborne CK: Prognostic factors for breast cancer: Have they met their promise? J Clin Oncol 10:679-682, 1992
14. Ravdin PM, DeLaurentiis M, Vendeley T, et al: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 86:1771-1774, 1994
15. Nemoto T, Vana J, Bedwani RN, et al: Management and survival of female breast cancer: Results of a national survey by the American College of Surgery. Cancer 45:2917-2924, 1980
16. Fisher B, Ravdin RG, Ausman RK, et al: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 168:337-356, 1968
17. Kinne DW: Controversies in primary breast cancer management. Am J Surg 166:502-508, 1993
18. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-772, 1981
19. Forrest A, Stewart H, Roberts M, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196:371-378, 1982
20. Boova R, Bonanni R, Rosato F: Patterns of axillary nodal involvement in breast cancer: Predictability of level one dissection. Ann Surg 196:642-644, 1982
21. Fisher C, Boyle S, Burke M, et al: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80:457-458, 1993
22. Steele R, Forrest A, Gibson T, et al: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial. Br J Surg 72:368-369, 1985
23. National Institutes of Health Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
24. Seigel BM, Mayzel KA, Love SM: Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 125:1144-1147, 1990
25. Benson EA, Thorogood J: The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 12:267-271, 1986
26. Delouche G, Bachelot F, Premont M, et al: Conservation treatment of early breast cancer: Long term results and complications. Int J Radiat Oncol Biol Phys 13:29-34, 1987
27. Rosen PP, Lesser ML, Kinne DW, et al: Discontinuous or 'skip' metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 197:276-283, 1983
28. Morton DL, Wen D-R, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
29. Hirsch JI, Tisnado J, Cho S-R, Beachley MC: Use of isosulfan blue for identification of lymphatic vessels: Experimental and clinical evaluation. AJR 139:1061-1064, 1982
30. Fisher ER, Swamidoss S, Lee CH, et al: Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42:2025-2031, 1978
31. Neville AM: Are breast cancer axillary node micrometastases worth detecting? J Pathol 161:283-284, 1990 (editorial)
32. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al: Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459-463, 1993
33. Giuliano AE, Barth AM, Spivack B, et al: Incidence and predictors of axillary metastasis in T1 breast cancer. J Am Coll Surg 183:185-189, 1996
34. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568, 1990
35. Trojani M, de Mascarel I, Bonichon F, et al: Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance. Br J Cancer 55:303-306, 1987
36. Sedmak DD, Meineke TA, Knechtges DS, et al: Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 2:516-520, 1989
37. Chen Z-L, Wen D-R, Coulson WF, et al: Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers 9:239-248, 1991
38. de Mascarel I, Bonichon F, Coindre JM, et al: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up. Br J Cancer 66:523-527, 1992
39. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993